Mereo BioPharma (MREO) Interest & Investment Income (2023 - 2026)
Mereo BioPharma (MREO) posted quarterly Interest & Investment Income of $327000.0 for Q1 2026, down 50.38% year-over-year from $659000.0 in Q1 2025, and down 22.33% quarter-over-quarter from $421000.0 in Q4 2025.
Mereo BioPharma (MREO) Interest & Investment Income (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Interest & Investment Income for 4 consecutive years, with $327000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income fell 50.38% year-over-year to $327000.0; the TTM figure through Mar 2026 stood at $1.8 million (down 40.27% YoY), while the FY2025 annual figure was $2.2 million, down 28.54% from the prior year.
- Interest & Investment Income declined to $327000.0 in Q1 2026 per MREO's latest filing, from $421000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $983000.0 in Q3 2024 and bottomed at $306000.0 in Q1 2023.
- Historically, Interest & Investment Income has averaged $590076.9 across 4 years, with a median of $589000.0 in 2025.
- Annual changes were most pronounced in 2024 — Interest & Investment Income soared 101.63% — and 2025, when it slumped 52.21%.
- Mereo BioPharma's Interest & Investment Income stood at $763000.0 in 2023, then grew by 15.47% to $881000.0 in 2024, then plunged by 52.21% to $421000.0 in 2025, then dropped by 22.33% to $327000.0 in 2026.
- Business Quant data shows MREO's Interest & Investment Income at $327000.0 in Q1 2026, $421000.0 in Q4 2025, and $504000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Mereo BioPharma | 47.39 Mn | 47.39 Mn | - | 278,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 278,000.00 |
| Mar 31, 2026 | 327,000.00 |
| Dec 31, 2025 | 421,000.00 |
| Sep 30, 2025 | 504,000.00 |
| Jun 30, 2025 | 589,000.00 |
| Mar 31, 2025 | 659,000.00 |
| Dec 31, 2024 | 881,000.00 |
| Sep 30, 2024 | 983,000.00 |
| Jun 30, 2024 | 559,000.00 |
| Mar 31, 2024 | 617,000.00 |
| Dec 31, 2023 | 763,000.00 |
| Sep 30, 2023 | 689,000.00 |
| Jun 30, 2023 | 373,000.00 |
| Mar 31, 2023 | 306,000.00 |